{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04905407",
            "orgStudyIdInfo": {
                "id": "SY-1425-202"
            },
            "organization": {
                "fullName": "Syros Pharmaceuticals",
                "class": "INDUSTRY"
            },
            "briefTitle": "Tamibarotene Plus Venetoclax/Azacitidine in Participants With Newly Diagnosed AML",
            "officialTitle": "Tamibarotene in Combination With Venetoclax and Azacitidine in Previously Untreated Adult Patients Selected for RARA-positive AML Who Are Ineligible for Standard Induction Therapy",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "tamibarotene-plus-venetoclax-azacitidine-in-participants-with-newly-diagnosed-aml"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "startDateStruct": {
                "date": "2021-08-26",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2028-04",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2028-04",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-05-24",
            "studyFirstSubmitQcDate": "2021-05-24",
            "studyFirstPostDateStruct": {
                "date": "2021-05-27",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-09",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-10",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Syros Pharmaceuticals",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "Tamibarotene is being studied as a treatment for participants with a type of leukemia called acute myeloid leukemia, or AML for short. Tamibarotene is being studied as a treatment for participants with AML whose cancer has a specific genetic abnormality characterized by the overexpression of the retinoic acid receptor alpha (RARA) gene. This genetic profile is found in about 3 of every 10 people with AML.\n\nDuring the trial, tamibarotene will be given with 2 other drugs that are already used together to treat people who have AML and who cannot start treatment with standard chemotherapy.",
            "detailedDescription": "This study consists of 3 parts. In Part 1, the safety, tolerability, and pharmacokinetic (PK) evaluation of tamibarotene/venetoclax/azacitidine combination will inform the appropriate tamibarotene dose to be combined with the standard of care (SOC) venetoclax/azacitidine in Part 2 and Part 3. In Part 2, participants will be randomized 1:1 to receive either tamibarotene/venetoclax/azacitidine or venetoclax/azacitidine to compare the clinical activity of the 2 combinations. In Part 3, tamibarotene will be added to the venetoclax/azacytidine regimen of a subset of Part 2 participants who experience progressive disease, relapse after initial complete remission (CR) or CR with incomplete blood count recovery (CRi) response, or treatment failure."
        },
        "conditionsModule": {
            "conditions": [
                "Acute Myeloid Leukemia"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 95,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Part 1: Tamibarotene/Venetoclax/Azacitidine",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive the tamibarotene/venetoclax/azacitidine triplet combination as follows: Azacitidine (intravenously or subcutaneously) at 75 milligrams (mg)/square meter (m\\^2) once daily, on Days 1 through 7 of each 28-day therapy cycle (per VIDAZA USPI). Alternative dosing of azacitidine (Days 1 through 5, 8, and 9) will be permitted throughout the study.\n\nVenetoclax (orally) daily on Days 1 through 28 per standard of care. Standard of care daily dosing is 100 mg on Day 1, 200 mg on Day 2, and 400 mg on Day 3 and beyond.\n\nTamibarotene 6 mg twice daily (BID) orally, on Days 8 through 28 of each 28-day therapy cycle. Tamibarotene will only be administered to participants who have been confirmed as RARA-positive.",
                    "interventionNames": [
                        "Drug: Tamibarotene",
                        "Drug: Venetoclax",
                        "Drug: Azacitidine"
                    ]
                },
                {
                    "label": "Part 2: Tamibarotene/Venetoclax/Azacitidine",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive the tamibarotene/venetoclax/azacitidine triplet combination at the dose and regimen selected in Part 1.",
                    "interventionNames": [
                        "Drug: Tamibarotene",
                        "Drug: Venetoclax",
                        "Drug: Azacitidine"
                    ]
                },
                {
                    "label": "Part 2: Venetoclax/Azacitidine",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Participants will receive the venetoclax/azacitidine combination at the dose and regimen selected in Part 1.",
                    "interventionNames": [
                        "Drug: Venetoclax",
                        "Drug: Azacitidine"
                    ]
                },
                {
                    "label": "Part 3: Tamibarotene/Venetoclax/Azacitidine",
                    "type": "EXPERIMENTAL",
                    "description": "Part 2 participants treated with venetoclax/azacitidine who experience progressive disease, relapse after initial CR or CRi response, or treatment failure may begin subsequent treatment in Part 3, where tamibarotene will be added to their regimen.",
                    "interventionNames": [
                        "Drug: Tamibarotene",
                        "Drug: Venetoclax",
                        "Drug: Azacitidine"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Tamibarotene",
                    "description": "Tamibarotene tablets will be administered per dose and schedule specified in the arm.",
                    "armGroupLabels": [
                        "Part 1: Tamibarotene/Venetoclax/Azacitidine",
                        "Part 2: Tamibarotene/Venetoclax/Azacitidine",
                        "Part 3: Tamibarotene/Venetoclax/Azacitidine"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Venetoclax",
                    "description": "Venetoclax tablets will be administered per dose and schedule specified in the arm.",
                    "armGroupLabels": [
                        "Part 1: Tamibarotene/Venetoclax/Azacitidine",
                        "Part 2: Tamibarotene/Venetoclax/Azacitidine",
                        "Part 2: Venetoclax/Azacitidine",
                        "Part 3: Tamibarotene/Venetoclax/Azacitidine"
                    ],
                    "otherNames": [
                        "Venclexta"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Azacitidine",
                    "description": "Azacitidine injection will be administered per dose and schedule specified in the arm.",
                    "armGroupLabels": [
                        "Part 1: Tamibarotene/Venetoclax/Azacitidine",
                        "Part 2: Tamibarotene/Venetoclax/Azacitidine",
                        "Part 2: Venetoclax/Azacitidine",
                        "Part 3: Tamibarotene/Venetoclax/Azacitidine"
                    ],
                    "otherNames": [
                        "Vidaza"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Part 1: Number of Participants With Adverse Events",
                    "timeFrame": "up to 3 years"
                },
                {
                    "measure": "Part 2: CR/CRi Rate",
                    "description": "CR/CRi rate is estimated by the proportion of participants who achieve CR/CRi (as determined by the investigator).",
                    "timeFrame": "up to 3 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Part 1: Overall Response Rate (ORR)",
                    "description": "Overall response assessment is comprised of CR, CRi, CR with partial hematologic recovery (CRh), morphologically leukemia-free state (MLFS), or partial remission (PR) (as determined by the investigator). ORR is estimated by the proportion of participants who achieve overall response.",
                    "timeFrame": "up to 3 years"
                },
                {
                    "measure": "Part 1: Plasma Concentration of Tamibarotene",
                    "timeFrame": "Day 8 and 22 of Cycle 1, Day 15 of Cycles 2 and 3 (cycle length = 28 days)"
                },
                {
                    "measure": "Part 2: Number of Participants With Adverse Events",
                    "timeFrame": "up to 3 years"
                },
                {
                    "measure": "Part 2: CR Rate",
                    "description": "CR rate is estimated by the proportion of participants who achieve CR (as determined by the investigator).",
                    "timeFrame": "up to 3 years"
                },
                {
                    "measure": "Part 2: CR/CRh Rate",
                    "description": "CR/CRh rate is estimated by the proportion of participants who achieve CR/CRh (as determined by the investigator).",
                    "timeFrame": "up to 3 years"
                },
                {
                    "measure": "Part 2: Duration of CR",
                    "description": "Duration of CR is defined as duration from the date of first documented evidence of CR to the date of relapse of disease (as determined by the investigator), or death due to any cause, whichever occurs first.",
                    "timeFrame": "up to 3 years"
                },
                {
                    "measure": "Part 2: Duration of CR/CRi",
                    "description": "Duration of CR/CRi is defined as duration from the date of first documented evidence of CR/CRi to the date of relapse of disease (as determined by the investigator), or death due to any cause, whichever occurs first.",
                    "timeFrame": "up to 3 years"
                },
                {
                    "measure": "Part 2: Duration of CR/CRh",
                    "description": "Duration of CR/CRh is defined as duration from the date of first documented evidence of CR/CRh to the date of relapse of disease (as determined by the investigator), or death due to any cause, whichever occurs first.",
                    "timeFrame": "up to 3 years"
                },
                {
                    "measure": "Part 2: Time to CR",
                    "description": "Time to CR is defined as the duration from the date of Cycle 1 Day 1 Visit to the date of the first documented evidence of CR as determined by the investigator.",
                    "timeFrame": "up to 3 years"
                },
                {
                    "measure": "Part 2: Time to CR/CRi",
                    "description": "Time to CR/CRi is defined as the duration from the date of Cycle 1 Day 1 Visit to the date of the first documented evidence of CR/CRi as determined by the investigator.",
                    "timeFrame": "up to 3 years"
                },
                {
                    "measure": "Part 2: Time to CR/CRh",
                    "description": "Time to CR/CRh is defined as the duration from the date of Cycle 1 Day 1 Visit to the date of the first documented evidence of CR/CRh as determined by the investigator.",
                    "timeFrame": "up to 3 years"
                },
                {
                    "measure": "Part 2: ORR",
                    "description": "Overall response assessment is comprised of CR, CRi, CRh, MLFS, or PR (as determined by the investigator). ORR is estimated by the proportion of participants who achieve overall response.",
                    "timeFrame": "up to 3 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Note: all inclusion/exclusion criteria should be met prior to the first dose of venetoclax/azacitidine on Cycle 1 Day 1 with the exception of the RARA-biomarker test result referenced in inclusion criterion 2, which should be positive by Cycle 1 Day 8 to continue treatment on study.\n\nInclusion Criteria:\n\n* All participants must have obtained a blood sample for RARA biomarker investigational assay testing prior to starting treatment on Cycle 1 Day 1. The results of the investigational biomarker assay for all participants must be confirmed as RARA-positive by Cycle 1 Day 8 to enroll (Part 1) or to be randomized (Part 2) in the study.\n* Participants must have newly diagnosed, previously untreated non-acute promyelocytic leukemia (APL) AML with a bone marrow or peripheral blood blast count \u226520% and must be unlikely to tolerate standard intensive chemotherapy at the time of Cycle 1 Day 1 Visit due to age, performance status, or comorbidities based on at least one of the following criteria:\n\n  * age \u226575 years old, or\n  * age \\<75 years old, with at least one of the following:\n\n    * Eastern Cooperative Oncology Group (ECOG) performance status of 3\n    * cardiac history of congestive heart failure (CHF) or documented ejection fraction (EF) \u226450%\n    * pulmonary disease with diffusing capacity of the lungs for carbon monoxide (DLCO) \u226465% or forced expiratory volume in one second (FEV1) \u226465%\n    * creatinine clearance \u226530 milliliters (mL)/minute (min) to \\<45 mL/min based on the Cockcroft-Gault glomerular filtration rate estimation\n    * hepatic impairment with total bilirubin \\>1.5 to \u22643.0 \\* upper limit of normal (ULN)\n    * any other comorbidity that the investigator judges to be incompatible with intensive chemotherapy, and reviewed and approved by the sponsor.\n\nExclusion Criteria:\n\n* Participants have APL.\n* Participants have known active central nervous system involvement with AML.\n* Prior treatment (before Cycle 1 Day 1) for the diagnosis of AML, myelodysplastic syndromes (MDS), or antecedent hematologic malignancy with any hypomethylating agent, venetoclax, chemotherapy, or hematopoietic stem cell transplantation (HSCT), with the exception of prior treatment with hydroxyurea.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Galina Craig",
                    "role": "CONTACT",
                    "phone": "857-321-8698",
                    "email": "gcraig@syros.com"
                },
                {
                    "name": "Tiffany Crowell",
                    "role": "CONTACT",
                    "email": "tcrowell@syros.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Michael Kelly Executive Medical Director, MD",
                    "affiliation": "Syros Pharmaceuticals",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "City of Hope",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Duarte",
                    "state": "California",
                    "zip": "91010",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.13945,
                        "lon": -117.97729
                    }
                },
                {
                    "facility": "UCLA Medical Center Division of Hematology/Oncology",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90095",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Bruck Habtermariam",
                            "role": "CONTACT",
                            "phone": "310-794-0242",
                            "email": "bhabtemariam@mednet.ucla.edu"
                        },
                        {
                            "name": "Kimberly Kelly",
                            "role": "CONTACT",
                            "phone": "310-206-5756",
                            "email": "kmkelly@mednet.ucla.edu"
                        },
                        {
                            "name": "Gary Schiller, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "University of Colorado",
                    "status": "RECRUITING",
                    "city": "Denver",
                    "state": "Colorado",
                    "zip": "80204",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Olivia Ondracek",
                            "role": "CONTACT",
                            "phone": "720-848-9384",
                            "email": "OLIVIA.ONDRACEK@CUANSCHUTZ.EDU"
                        },
                        {
                            "name": "Christine McMahon, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.73915,
                        "lon": -104.9847
                    }
                },
                {
                    "facility": "Sarah Cannon Research Institute at Colorado Blood Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Denver",
                    "state": "Colorado",
                    "zip": "80218",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sonya Grohowski",
                            "role": "CONTACT",
                            "phone": "720-754-8074",
                            "email": "sonya.grohowski@sarahcannon.com"
                        },
                        {
                            "name": "James Vick",
                            "role": "CONTACT",
                            "phone": "7207548075",
                            "email": "james.vick@sarahcannon.com"
                        },
                        {
                            "name": "Alireza Eghtedar, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.73915,
                        "lon": -104.9847
                    }
                },
                {
                    "facility": "Hartford HealthCare",
                    "status": "RECRUITING",
                    "city": "Hartford",
                    "state": "Connecticut",
                    "zip": "06102",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Christopher Sampson",
                            "role": "CONTACT",
                            "phone": "860-972-5361",
                            "email": "christopher.sampson@hhchealth.org"
                        },
                        {
                            "name": "Devendra KC, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.76371,
                        "lon": -72.68509
                    }
                },
                {
                    "facility": "Northside",
                    "status": "RECRUITING",
                    "city": "Atlanta",
                    "state": "Georgia",
                    "zip": "30342",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Nancy Shegda",
                            "role": "CONTACT",
                            "email": "nancy.shegda@northside.com"
                        },
                        {
                            "name": "Caitlin Guzowski",
                            "role": "CONTACT",
                            "email": "caitlin.guzowski@northside.com"
                        },
                        {
                            "name": "Melhem Solh, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.749,
                        "lon": -84.38798
                    }
                },
                {
                    "facility": "Saint Alphonsus Regional Medical Center",
                    "status": "WITHDRAWN",
                    "city": "Boise",
                    "state": "Idaho",
                    "zip": "83706",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 43.6135,
                        "lon": -116.20345
                    }
                },
                {
                    "facility": "University of Mississippi",
                    "status": "RECRUITING",
                    "city": "Jackson",
                    "state": "Mississippi",
                    "zip": "39213",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Stephanie Elkins, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.29876,
                        "lon": -90.18481
                    }
                },
                {
                    "facility": "HCA Midwest Research Medical Center",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Kansas City",
                    "state": "Missouri",
                    "zip": "64132",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.09973,
                        "lon": -94.57857
                    }
                },
                {
                    "facility": "Atlantic Health",
                    "status": "RECRUITING",
                    "city": "Morristown",
                    "state": "New Jersey",
                    "zip": "07960",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Caroline Sabatino",
                            "role": "CONTACT",
                            "email": "caroline.sabatino@atlantichealth.org"
                        },
                        {
                            "name": "Donna Rotyliano",
                            "role": "CONTACT",
                            "email": "donna.rotyliano@atlantichealth.org"
                        },
                        {
                            "name": "Mohamad Cherry",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.79677,
                        "lon": -74.48154
                    }
                },
                {
                    "facility": "Montefiore Medical Center",
                    "status": "WITHDRAWN",
                    "city": "Bronx",
                    "state": "New York",
                    "zip": "10467",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.84985,
                        "lon": -73.86641
                    }
                },
                {
                    "facility": "Roswell Park Comprehensive Cancer Center",
                    "status": "RECRUITING",
                    "city": "Buffalo",
                    "state": "New York",
                    "zip": "14263",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Julie Guido",
                            "role": "CONTACT",
                            "phone": "716-845-3340",
                            "email": "julie.guido@rosewellpark.org"
                        },
                        {
                            "name": "Laurie Smith",
                            "role": "CONTACT",
                            "phone": "7737463121",
                            "email": "laurie.smith@roswellpark.org"
                        },
                        {
                            "name": "Eunice Wang, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.88645,
                        "lon": -78.87837
                    }
                },
                {
                    "facility": "Icahn School of Medicine at Mount Sinai",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10029",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Mikaela Dougherty",
                            "role": "CONTACT",
                            "phone": "212-241-3659",
                            "email": "mikaela.dougherty@mssm.edu"
                        },
                        {
                            "name": "Jonathan Feld, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Memorial Sloan Kettering Cancer Center",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10065",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "New York Medical College",
                    "status": "WITHDRAWN",
                    "city": "Valhalla",
                    "state": "New York",
                    "zip": "10595",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.07482,
                        "lon": -73.77513
                    }
                },
                {
                    "facility": "Novant Health",
                    "status": "RECRUITING",
                    "city": "Charlotte",
                    "state": "North Carolina",
                    "zip": "28204",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Joanne Nicholls",
                            "role": "CONTACT",
                            "email": "jnicholls@novanthealth.org"
                        },
                        {
                            "name": "James Dugan, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.22709,
                        "lon": -80.84313
                    }
                },
                {
                    "facility": "The Ohio State University James Cancer Hospital",
                    "status": "RECRUITING",
                    "city": "Columbus",
                    "state": "Ohio",
                    "zip": "43210",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Seth McAtee",
                            "role": "CONTACT",
                            "phone": "614-685-6397",
                            "email": "seh.McAtee@osumc.edu"
                        },
                        {
                            "name": "Melissa Koffi",
                            "role": "CONTACT",
                            "phone": "6146854356",
                            "email": "melissa.koffi@osumc.edu"
                        },
                        {
                            "name": "Uma Borate, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.96118,
                        "lon": -82.99879
                    }
                },
                {
                    "facility": "Oregon Health & Science University",
                    "status": "RECRUITING",
                    "city": "Portland",
                    "state": "Oregon",
                    "zip": "97239",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Tara Williams",
                            "role": "CONTACT",
                            "phone": "503-346-0010",
                            "email": "lundbert@ohsu.edu"
                        },
                        {
                            "name": "Rachel Cook, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.52345,
                        "lon": -122.67621
                    }
                },
                {
                    "facility": "MD Anderson Cancer Center",
                    "status": "WITHDRAWN",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "CHU Lyon Sud",
                    "status": "RECRUITING",
                    "city": "Pierre-B\u00e9nite",
                    "state": "Pierre Benite",
                    "zip": "69495",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Mohamed El-Hamri",
                            "role": "CONTACT",
                            "email": "mohamed.el-hamri@chu-lyon.fr"
                        },
                        {
                            "name": "Ma\u00ebl Heiblig",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.7009,
                        "lon": 4.82511
                    }
                },
                {
                    "facility": "CHU Angers",
                    "status": "RECRUITING",
                    "city": "Angers",
                    "zip": "49000",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Celine Marie",
                            "role": "CONTACT",
                            "phone": "33241355877",
                            "email": "cemarie@chu-angers.fr"
                        },
                        {
                            "name": "Sylvain Thepot, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 47.46667,
                        "lon": -0.55
                    }
                },
                {
                    "facility": "CH de la C\u00f4te Basque",
                    "status": "RECRUITING",
                    "city": "Bayonne",
                    "zip": "64100",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Antoine Bernier",
                            "role": "CONTACT",
                            "email": "abernier@ch-cotebasque.fr"
                        },
                        {
                            "name": "Jean-Baptiste Robin",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.48333,
                        "lon": -1.48333
                    }
                },
                {
                    "facility": "H\u00f4pital Avicenne H\u00e9matologie Clinique",
                    "status": "RECRUITING",
                    "city": "Bobigny",
                    "zip": "93000",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Geoffrey Edouart",
                            "role": "CONTACT",
                            "email": "geoffrey.edouart@aphp.fr"
                        },
                        {
                            "name": "Thorsten Braun, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 48.9,
                        "lon": 2.45
                    }
                },
                {
                    "facility": "CHU de Caen Normandie",
                    "status": "RECRUITING",
                    "city": "Caen",
                    "zip": "14033",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Lea Renault",
                            "role": "CONTACT",
                            "email": "renault-l@chu-caen.fr"
                        },
                        {
                            "name": "Sylvain Chantepie, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 49.18585,
                        "lon": -0.35912
                    }
                },
                {
                    "facility": "CHU Limoges",
                    "status": "RECRUITING",
                    "city": "Limoges",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Marie Pierre Gourin",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Marie Pierre Gourin, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.83153,
                        "lon": 1.25781
                    }
                },
                {
                    "facility": "CHU de Nantes - H\u00f4tel Dieu",
                    "status": "RECRUITING",
                    "city": "Nantes",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Pierre Peterlin, MD",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Pierre Peterlin, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 47.21725,
                        "lon": -1.55336
                    }
                },
                {
                    "facility": "H\u00f4pital l'Archet- CHU de Nice",
                    "status": "RECRUITING",
                    "city": "Nice",
                    "zip": "06202",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Melani Billi",
                            "role": "CONTACT",
                            "email": "billi.m@chu-nice.fr"
                        },
                        {
                            "name": "Thomas Cluzeau",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.70313,
                        "lon": 7.26608
                    }
                },
                {
                    "facility": "CHU de Bordeaux - H\u00f4pital Haut-L\u00e9v\u00e8que",
                    "status": "RECRUITING",
                    "city": "Pessac",
                    "zip": "33604",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Corentin Rouvray",
                            "role": "CONTACT",
                            "email": "corentin.rouvray@chu-bordeaux.fr"
                        },
                        {
                            "name": "Arnaud Pigneux",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.81011,
                        "lon": -0.64129
                    }
                },
                {
                    "facility": "H\u00f4pital Saint-Louis",
                    "status": "RECRUITING",
                    "city": "Vellefaux",
                    "zip": "75475",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Blandine Beve",
                            "role": "CONTACT",
                            "email": "blandine.beve@aphp.fr"
                        },
                        {
                            "name": "Pierre Fenaux",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 47.55295,
                        "lon": 6.1397
                    }
                },
                {
                    "facility": "Centre Hospitalier de Versailles",
                    "status": "RECRUITING",
                    "city": "Versailles",
                    "zip": "78150",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Anais Beulaygue",
                            "role": "CONTACT",
                            "phone": "33139239782",
                            "email": "abeulaygue@ght78sud.fr"
                        },
                        {
                            "name": "Philippe Rousselot, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 48.8,
                        "lon": 2.13333
                    }
                },
                {
                    "facility": "Institut Gustave Roussy",
                    "status": "RECRUITING",
                    "city": "Villejuif",
                    "zip": "94800",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Laetitia Pireyre",
                            "role": "CONTACT",
                            "email": "laetitia.pireyre@gustaveroussy.fr"
                        },
                        {
                            "name": "Stephane De Botton",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 48.7939,
                        "lon": 2.35992
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M10945",
                    "name": "Leukemia",
                    "relevance": "LOW"
                },
                {
                    "id": "M10955",
                    "name": "Leukemia, Myeloid",
                    "relevance": "LOW"
                },
                {
                    "id": "M18127",
                    "name": "Leukemia, Myeloid, Acute",
                    "relevance": "LOW"
                },
                {
                    "id": "T3995",
                    "name": "Myeloid Leukemia",
                    "asFound": "Myeloid Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T182",
                    "name": "Acute Myeloid Leukemia",
                    "asFound": "Acute Myeloid Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T188",
                    "name": "Acute Non Lymphoblastic Leukemia",
                    "relevance": "LOW"
                },
                {
                    "id": "T170",
                    "name": "Acute Graft Versus Host Disease",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000001374",
                    "term": "Azacitidine"
                },
                {
                    "id": "C000579720",
                    "term": "Venetoclax"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000964",
                    "term": "Antimetabolites, Antineoplastic"
                },
                {
                    "id": "D000000963",
                    "term": "Antimetabolites"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M249656",
                    "name": "Venetoclax",
                    "asFound": "0.1",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4673",
                    "name": "Azacitidine",
                    "asFound": "Pilot Study",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4281",
                    "name": "Antimetabolites",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}